Based on our previous study demonstrating a critical role for CD8+ T cells in controlling RO ZIKV infection [22], we speculate that high-dose viral challenge more effectively activates multiple innate immune and CD8+ T cell responses than does low-dose challenge. The gene discussed is CD8A; the disease is Zika virus infectious disease.